Vetoquinol represents one of the only animal health companies on the list.
FORT WORTH, TEXAS (March 31, 2021) – Vetoquinol USA is one of the country’s top 20 workplaces in biotechnology and pharmaceuticals, according to Fortune’s annual rankings.
The rankings were determined after the analytics firm Great Place to Work conducted America’s largest ongoing annual workforce study, which included 4.1 million employees in 2021. Vetoquinol USA has been certified as a Great Place to Work for the last four years.
“We are honored to be recognized by Fortune as one of the 20 Best Workplaces in Biotechnology and Pharmaceuticals,” said Eric M. Alsup, DVM, Country Manager, Vetoquinol USA. “Given this year's extraordinary economic and health circumstances, I’m incredibly proud of our team for helping us continue to serve our customers and meet our business goals through collaboration, tenacity, and a positive attitude. Even as we navigate this uncertain time, we strive every day to be our best and nurture the strongest team.”
Last year, Vetoquinol USA doubled its efforts to create a positive employee experience by emphasizing work/life balance; creating opportunities for peer-to-peer support; actively seeking employee input and measuring engagement; creating new training and development programs; fostering a culture that encourages volunteerism and community involvement; and growing its diversity and inclusion program.
“At Vetoquinol USA, we believe ‘you win with people,’” said Bill Miller, Head of Human Resources, Vetoquinol USA. “We are committed to investing in, developing, and empowering our staff who will take Vetoquinol USA into the future.”
Globally, Vetoquinol also received the Animal Pharm award for Best European Company and recognition as one of Le Point’s Best French Veterinary Laboratories for Corporate Social Responsibility.
About Vetoquinol USA
Headquartered in Fort Worth, Texas, Vetoquinol USA is owned by Vetoquinol S.A., an independent, family-owned French pharmaceutical company founded in 1933. Dedicated exclusively to animal health, Vetoquinol USA is focused on the development, production and marketing of FDA, EPA, NASC and AAFCO-regulated pharmaceutical, nutritional and dermatological products for small and large animals.
Latest news
FDA Approves Extended Expiration Date for Clevor® (ropinirole ophthalmic solution)
August 2024
Press Release: Fluorescent Light Energy Enhances Post Mastectomy Wound Healing in Dogs
August 2024
UpCard®-CA1 (torsemide oral solution) is Now Available
July 2024